Safety and Efficacy Study of Immunotherapy With Rituximab and Interleukin-2 in Patients With Non-Hodgkin's Lymphoma
Clinical trial NCT00994643 · COMPLETED
Trial details
- NCT number
- NCT00994643
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-02-05
- Primary completion
- 2014-06-25
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.